Citations to this article
Wee Siong Chew, … , E. Shyong Tai, Deron R. Herr
Published June 4, 2019
Citation Information: JCI Insight. 2019;4(13):e126925. https://doi.org/10.1172/jci.insight.126925.
Citation Information: JCI Insight. 2019;4(13):e126925. https://doi.org/10.1172/jci.insight.126925.
Abstract
BACKGROUND Sphingolipids (SPs) are ubiquitous, structurally diverse molecules that include ceramides, sphingomyelins (SMs), and sphingosines. They are involved in various pathologies, including obesity and type 2 diabetes mellitus (T2DM). Therefore, it is likely that perturbations in plasma concentrations of SPs are associated with disease. Identifying these associations may reveal useful biomarkers or provide insight into disease processes.METHODS We performed a lipidomics evaluation of molecularly distinct SPs in the plasma of 2302 ethnically Chinese Singaporeans using electrospray ionization mass spectrometry coupled with liquid chromatography. SP profiles were compared to clinical and biochemical characteristics, and subjects were evaluated with follow-up visits for 11 years.RESULTS We found that ceramides correlated positively but hexosylceramides correlated negatively with BMI and homeostatic model assessment of insulin resistance (HOMA-IR). Furthermore, SPs with a d16:1 sphingoid backbone correlated more positively with BMI and HOMA-IR, while d18:2 SPs correlated less positively, relative to canonical d18:1 SPs. We also found that higher concentrations of 2 distinct SMs were associated with a higher risk of T2DM (HR 1.45 with 95% CI 1.18–1.78 for SM d16:1/18:0 and HR 1.40 with 95% CI 1.17–1.68 for SM d18:1/18:0).CONCLUSIONS We identified significant associations between SPs and obesity/T2DM characteristics, specifically, those of hexosylceramides, d16:1 SPs, and d18:2 SPs. This suggests that the balance of SP metabolism, rather than ceramide accumulation, is associated with the pathology of obesity. We further identified 2 specific SPs that may represent prognostic biomarkers for T2DM.FUNDING National University Health System (NUHSRO/2014/085/AF-Partner/01) and the National Research Foundation Investigatorship grant (NRF-NRFI2015-05).
Authors
Wee Siong Chew, Federico Torta, Shanshan Ji, Hyungwon Choi, Husna Begum, Xueling Sim, Chin Meng Khoo, Eric Yin Hao Khoo, Wei-Yi Ong, Rob M. Van Dam, Markus R. Wenk, E. Shyong Tai, Deron R. Herr
Total citations by year
Citation information
Citations to this article (79)
| Title and authors | Publication | Year |
|---|---|---|
|
CerS6 links ceramide metabolism to innate immune responses in diabetic kidney disease
Zhu Z, Cao Y, Jian Y, Hu H, Yang Q, Hao Y, Jiang H, Luo Z, Yang X, Li W, Hu J, Liu H, Liang W, Ding G, Chen Z |
Nature Communications | 2025 |
|
Elevated Very-Long-Chain Ceramides in the Vitreous Humor of Patients With Proliferative Diabetic Retinopathy
Chen YY, Yang CM, Yang CH, Ho TC, Hsieh YT, Lai TT, Tsai TH, Huang SY |
Investigative Ophthalmology & Visual Science | 2025 |
|
A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer’s disease, and their co-morbidities
Pan Y, Li J, Lin P, Wan L, Qu Y, Cao L, Wang L |
Frontiers in pharmacology | 2024 |
|
ReTimeML: a retention time predictor that supports the LC-MS/MS analysis of sphingolipids.
Allwright M, Guennewig B, Hoffmann AE, Rohleder C, Jieu B, Chung LH, Jiang YC, Lemos Wimmer BF, Qi Y, Don AS, Leweke FM, Couttas TA |
Scientific Reports | 2024 |
|
Effects of wolfberry (Lycium barbarum) consumption on the human plasma lipidome and its association with cardiovascular disease risk factors: a randomized controlled trial of middle-aged and older adults.
Toh DWK, Zhou H, Cazenave-Gassiot A, Choi H, Burla B, Bendt AK, Wenk MR, Ling LH, Kim JE |
Frontiers in Nutrition | 2024 |
|
Illuminating the dark space of neutral glycosphingolipidome by selective enrichment and profiling at multi-structural levels
Wang Z, Zhang D, Wu J, Zhang W, Xia Y |
Nature Communications | 2024 |
|
Moderate-intensity Combined Training Induces Lipidomic Changes in Individuals With Obesity and Type 2 Diabetes
Duft RG, Bonfante IL, Palma-Duran SA, Chacon-Mikahil MP, Griffin JL, Cavaglieri CR |
The Journal of clinical endocrinology and metabolism | 2024 |
|
Lipid profile alterations and biomarker identification in type 1 diabetes mellitus patients under glycemic control
Cai Y, Qi X, Zheng Y, Zhang J, Su H |
BMC Endocrine Disorders | 2024 |
|
Ceramides are fuel gauges on the drive to cardiometabolic disease
Wilkerson JL, Tatum SM, Holland WL, Summers SA |
Physiological Reviews | 2024 |
|
Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies
Berkowitz L, Razquin C, Salazar C, Biancardi F, Estruch R, Ros E, Fitó M, Corella D, Coe CL, Ryff CD, Ruiz-Canela M, Salas-Salvado J, Wang D, Hu FB, Deik A, Martínez-Gonzalez MA, Rigotti A |
Cardiovascular Diabetology | 2024 |
|
Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosis
Ghezzi L, Tosti V, Shi L, Cantoni C, Mikesell R, Lancia S, Zhou Y, Obert K, Dula C, Sen MK, Ge A, Tolentino M, Bollman B, Don AS, Matarese G, Colamatteo A, La Rocca C, Lepore MT, Raji CA, Rahmani F, Wu GF, Naismith RT, Fontana L, Cross AH, Salter A, Piccio L |
Journal of Neurology, Neurosurgery, and Psychiatry | 2024 |
|
Metabolic Phenotyping of BMI to Characterize Cardiometabolic Risk and Outcomes in Large Population Cohorts
Habtamu Beyene, Gavriel Olshansky, Corey Giles, Kevin Huynh, Michelle Cinel, Natalie Mellett, Alexander Smith, Thomas Meikle, Gerald Watts, Joseph Hung, Jennie Hui, Gemma Cadby, John Beilby, John Blangero, Eric Moses, Jonathan Shaw, Dianna Magliano, Peter Meikle |
Nature Communications | 2023 |
|
The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers
Di Pietro P, Izzo C, Abate AC, Iesu P, Rusciano MR, Venturini E, Visco V, Sommella E, Ciccarelli M, Carrizzo A, Vecchione C |
Biomolecules | 2023 |
|
Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients
Yang J, Wang M, Yang D, Yan H, Wang Z, Yan D, Guo N |
Frontiers in Endocrinology | 2023 |
|
Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver Injury
Gai Z, Samodelov SL, Alecu I, Hornemann T, Grove JI, Aithal GP, Visentin M, Kullak-Ublick GA |
International journal of molecular sciences | 2023 |
|
Plasma lipidomic profiling reveals metabolic adaptations to pregnancy and signatures of cardiometabolic risk: a preconception and longitudinal cohort study
Chen L, Mir SA, Bendt AK, Chua EW, Narasimhan K, Tan KM, Loy SL, Tan KH, Shek LP, Chan J, Yap F, Meaney MJ, Chan SY, Chong YS, Gluckman PD, Eriksson JG, Karnani N, Wenk MR |
BMC Medicine | 2023 |
|
The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus
Ağagündüz D, Icer MA, Yesildemir O, Koçak T, Kocyigit E, Capasso R |
Journal of Translational Medicine | 2023 |
|
Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
Denimal D, Bergas V, Pais-de-Barros JP, Simoneau I, Demizieux L, Passilly-Degrace P, Bouillet B, Petit JM, Rouland A, Bataille A, Duvillard L, Vergès B |
Cardiovascular Diabetology | 2023 |
|
Extracellular vesicles from human plasma for biomarkers discovery: Impact of anticoagulants and isolation techniques.
Bettio V, Mazzucco E, Antona A, Cracas S, Varalda M, Venetucci J, Bruno S, Chiabotto G, Venegoni C, Vasile A, Chiocchetti A, Quaglia M, Camussi G, Cantaluppi V, Panella M, Rolla R, Manfredi M, Capello D |
PloS one | 2023 |
|
Enhancing de novo ceramide synthesis induced by bisphenol A exposure aggravates metabolic derangement during obesity
Wang G, Hong X, Yu J, Zhang Y, Li Y, Li Z, Zhu Z, Yuan S, Zhang X, Wang S, Zhu F, Wang Y, Wu C, Su P, Shen T |
Molecular Metabolism | 2023 |
|
Replacement of dietary saturated with unsaturated fatty acids is associated with beneficial effects on lipidome metabolites: a secondary analysis of a randomized trial
Sellem L, Eichelmann F, Jackson KG, Wittenbecher C, Schulze MB, Lovegrove JA |
The American journal of clinical nutrition | 2023 |
|
Hibernation and plasma lipids in free-ranging brown bears-implications for diabetes.
Tekin H, Frøbert O, Græsli AR, Kindberg J, Bilgin M, Buschard K |
PloS one | 2023 |
|
Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials
Wretlind A, Curovic VR, de Zawadzki A, Suvitaival T, Xu J, Zobel EH, von Scholten BJ, Ripa RS, Kjaer A, Hansen TW, Vilsbøll T, Vestergaard H, Rossing P, Legido-Quigley C |
Lipids in Health and Disease | 2023 |
|
Association of healthy dietary patterns and cardiorespiratory fitness in the community
Mi MY, Gajjar P, Walker ME, Miller P, Xanthakis V, Murthy VL, Larson MG, Vasan RS, Shah RV, Lewis GD, Nayor M |
European Journal of Preventive Cardiology | 2023 |
|
Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes
Wretlind A, Curovic VR, Suvitaival T, Theilade S, Tofte N, Winther SA, Vilsbøll T, Vestergaard H, Rossing P, Legido-Quigley C |
Diabetes | 2023 |
|
Plasma metabolomics supports non-fasted sampling for metabolic profiling across a spectrum of glucose tolerance in the Nile rat model for type 2 diabetes
Anderson BJ, Curtis AM, Jen A, Thomson JA, Clegg DO, Jiang P, Coon JJ, Overmyer KA, Toh H |
Lab Animal | 2023 |
|
Lipidomics analysis of impaired glucose tolerance and type 2 diabetes mellitus in overweight or obese elderly adults.
Shao F, Hu X, Li J, Bai B, Tian L |
Endocrine Connections | 2023 |
|
Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer’s disease and vascular dementia
Chua XY, Torta F, Chong JR, Venketasubramanian N, Hilal S, Wenk MR, Chen CP, Arumugam TV, Herr DR, Lai MK |
Alzheimer's research & therapy | 2023 |
|
Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update
Kale D, Fatangare A, Phapale P, Sickmann A |
Cells | 2023 |
|
Associations of plasma sphingolipids with measures of insulin sensitivity, β-cell function, and incident diabetes in Japanese Americans
Bae JC, Wander PL, Lemaitre RN, Fretts AM, Sitlani CM, Bui HH, Thomas MK, Leonetti D, Fujimoto WY, Boyko EJ, Utzschneider KM |
Nutrition, Metabolism, and Cardiovascular Diseases | 2023 |
|
Ten metabolites-based algorithm predicts the future development of type 2 diabetes in Chinese.
Su X, Cheung CYY, Zhong J, Ru Y, Fong CHY, Lee CH, Liu Y, Cheung CKY, Lam KSL, Xu A, Cai Z |
Journal of advanced research | 2023 |
|
The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes
L Zhang, Y Hu, Y An, Q Wang, J Liu, G Wang |
Frontiers in Endocrinology | 2022 |
|
Emerging Roles of Ceramide in Cardiovascular Diseases
H Shu, Y Peng, W Hang, N Li, N Zhou, D Wang |
Aging and disease | 2022 |
|
Metabolomics and Type 2 Diabetes Risk: An Updated Systematic Review and Meta-analysis of Prospective Cohort Studies
J Morze, C Wittenbecher, L Schwingshackl, A Danielewicz, A Rynkiewicz, F Hu, M Guasch-Ferré |
Diabetes care | 2022 |
|
Mechanisms contributing to adverse outcomes of COVID-19 in obesity
M Sudhakar, S Winfred, G Meiyazhagan, D Venkatachalam |
Molecular and Cellular Biochemistry | 2022 |
|
Implications of Sphingolipid Metabolites in Kidney Diseases
S kumar Mallela, S Merscher, A Fornoni |
International journal of molecular sciences | 2022 |
|
Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated Risk
L Berkowitz, F Cabrera-Reyes, C Salazar, C Ryff, C Coe, A Rigotti |
Frontiers in Cardiovascular Medicine | 2022 |
|
Exploration of Potential Biomarkers for Type 2 Diabetes by UPLC-QTOF-MS and WGCNA of Skin Surface Lipids
H Li, Y Ma, N Feng, W Wang, C He |
Clinical, cosmetic and investigational dermatology | 2022 |
|
Plasma Metabolites Associated with a Protein‐Rich Dietary Pattern: Results from the OmniHeart Trial
H Kim, A Lichtenstein, K White, K Wong, E Miller, J Coresh, L Appel, C Rebholz |
Molecular Nutrition & Food Research | 2022 |
|
Insulin-inducible THRSP maintains mitochondrial function and regulates sphingolipid metabolism in human adipocytes
M Ahonen, M Höring, V Nguyen, S Qadri, J Taskinen, M Nagaraj, M Wabitsch, P Fischer-Posovszky, Y Zhou, G Liebisch, P Haridas, H Yki-Järvinen, V Olkkonen |
Molecular Medicine | 2022 |
|
Novel Plasma Metabolomic Markers Associated with Diabetes Progression in Older Puerto Ricans
Rivas-Tumanyan S, Pacheco LS, Haslam DE, Liang L, Tucker KL, Joshipura KJ, Bhupathiraju SN |
Metabolites | 2022 |
|
Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation
Eichelmann F, Sellem L, Wittenbecher C, Jäger S, Kuxhaus O, Prada M, Cuadrat R, Jackson KG, Lovegrove JA, Schulze MB |
Circulation | 2022 |
|
A set of gene knockouts as a resource for global lipidomic changes
Spiegel A, Lauber C, Bachmann M, Heninger AK, Klose C, Simons K, Sarov M, Gerl MJ |
Scientific Reports | 2022 |
|
Population-based plasma lipidomics reveals developmental changes in metabolism and signatures of obesity risk: a mother-offspring cohort study
Mir SA, Chen L, Burugupalli S, Burla B, Ji S, Smith AA, Narasimhan K, Ramasamy A, Tan KM, Huynh K, Giles C, Mei D, Wong G, Yap F, Tan KH, Collier F, Saffery R, Vuillermin P, Bendt AK, Burgner D, Ponsonby AL, Lee YS, Chong YS, Gluckman PD, Eriksson JG, Meikle PJ, Wenk MR, Karnani N |
BMC Medicine | 2022 |
|
Type 2 diabetes disrupts circadian orchestration of lipid metabolism and membrane fluidity in human pancreatic islets
Petrenko V, Sinturel F, Loizides-Mangold U, Montoya JP, Chera S, Riezman H, Dibner C |
PLoS Biology | 2022 |
|
Serum lipidomics profiles reveal potential lipid markers for prediabetes and type 2 diabetes in patients from multiple communities
Xuan Q, Hu C, Zhang Y, Wang Q, Zhao X, Liu X, Wang C, Jia W, Xu G |
Frontiers in Endocrinology | 2022 |
|
Serum dihydroceramides correlate with insulin sensitivity in humans and decrease insulin sensitivity in vitro
Zarini S, Brozinick JT, Zemski Berry KA, Garfield A, Perreault L, Kerege A, Bui HH, Sanders P, Siddall P, Kuo MS, Bergman BC |
Journal of lipid research | 2022 |
|
A Comprehensive Profiling of Cellular Sphingolipids in Mammalian Endothelial and Microglial Cells Cultured in Normal and High-Glucose Conditions
Mondal K, Grambergs RC, Gangaraju R, Mandal N |
Cells | 2022 |
|
Specific triacylglycerol, diacylglycerol, and lyso-phosphatidylcholine species for the prediction of type 2 diabetes: a ~ 16-year prospective study in Chinese.
Zhong J, Cheung CYY, Su X, Lee CH, Ru Y, Fong CHY, Liu Y, Cheung CKY, Lam KSL, Cai Z, Xu A |
Cardiovascular Diabetology | 2022 |
|
Salvia miltiorrhiza extract may exert an anti-obesity effect in rats with high-fat diet-induced obesity by modulating gut microbiome and lipid metabolism
Ai ZL, Zhang X, Ge W, Zhong YB, Wang HY, Zuo ZY, Liu DY |
World Journal of Gastroenterology | 2022 |
|
Glycosphingolipids in Diabetes, Oxidative Stress, and Cardiovascular Disease: Prevention in Experimental Animal Models
Balram A, Thapa S, Chatterjee S |
International journal of molecular sciences | 2022 |
|
Serum sphingolipid profiling as a novel biomarker for metabolic syndrome characterization
Berkowitz L, Salazar C, Ryff CD, Coe CL, Rigotti A |
Frontiers in Cardiovascular Medicine | 2022 |
|
Plasma Sphingolipid Profile in Association with Incident Metabolic Syndrome in a Chinese Population-Based Cohort Study
H Yun, QB Qi, G Zong, QQ Wu, ZH Niu, SS Chen, HX Li, L Sun, R Zeng, X Lin |
Nutrients | 2021 |
|
Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes
AM Fretts, PN Jensen, AN Hoofnagle, B McKnight, BV Howard, J Umans, CM Sitlani, DS Siscovick, IB King, L Djousse, N Sotoodehnia, RN Lemaitre |
Journal of lipid research | 2021 |
|
Longitudinal Plasma Lipidome and Risk of Type 2 Diabetes in a Large Sample of American Indians With Normal Fasting Glucose: The Strong Heart Family Study
G Miao, Y Zhang, Z Huo, W Zeng, J Zhu, JG Umans, G Wohlgemuth, D Pedrosa, B DeFelice, SA Cole, AM Fretts, ET Lee, BV Howard, O Fiehn, J Zhao |
Diabetes care | 2021 |
|
Dietary Fat and Protein Intake in Relation to Plasma Sphingolipids as Determined by a Large-Scale Lipidomic Analysis
JY Seah, WS Chew, F Torta, CM Khoo, MR Wenk, DR Herr, ES Tai, RM van Dam |
Metabolites | 2021 |
|
Association of plasma ceramides with prevalent and incident type 2 diabetes mellitus in middle and older aged adults
SB Dugani, LR Christenson, JA Aakre, HH Bui, A Vella, MM Mielke |
Diabetes Research and Clinical Practice | 2021 |
|
Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status
K Guo, M Savelieff, A Rumora, F Alakwaa, B Callaghan, J Hur, E Feldman |
The Journal of clinical endocrinology and metabolism | 2021 |
|
Metabolic View on Human Healthspan: A Lipidome-Wide Association Study
J Carrard, H Gallart-Ayala, D Infanger, T Teav, J Wagner, R Knaier, F Colledge, L Streese, K Königstein, T Hinrichs, H Hanssen, J Ivanisevic, A Schmidt-Trucksäss |
Metabolites | 2021 |
|
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research
A Rohatgi, M Westerterp, A von Eckardstein, A Remaley, KA Rye |
Circulation | 2021 |
|
Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?
M Mah, M Febbraio, S Turpin-Nolan |
Frontiers in Endocrinology | 2021 |
|
AdipoAtlas: A reference lipidome for human white adipose tissue
M Lange, G Angelidou, Z Ni, A Criscuolo, J Schiller, M Blüher, M Fedorova |
Cell reports. Medicine | 2021 |
|
Identification of circulating sphingosine kinase-related metabolites for prediction of type 2 diabetes
Q Chen, W Wang, MF Xia, Y Lu, H Bian, C Yu, XY Li, MA Vadas, X Gao, HD Lin, P Xia |
Journal of Translational Medicine | 2021 |
|
Impact of Pelvic Radiation Therapy for Prostate Cancer on Global Metabolic Profiles and Microbiota-Driven Gastrointestinal Late Side Effects: A Longitudinal Observational Study
MR Ferreira, CJ Sands, JV Li, JN Andreyev, E Chekmeneva, S Gulliford, J Marchesi, MR Lewis, DP Dearnaley |
International journal of radiation oncology, biology, physics | 2021 |
|
Prospective analysis of circulating metabolites and endometrial cancer risk
L Dossus, E Kouloura, C Biessy, V Viallon, AP Siskos, N Dimou, S Rinaldi, MA Merritt, N Allen, R Fortner, R Kaaks, E Weiderpass, IT Gram, JA Rothwell, L Lécuyer, G Severi, MB Schulze, TH Nøst, M Crous-Bou, MJ Sánchez, P Amiano, SM Colorado-Yohar, AB Gurrea, JA Schmidt, D Palli, C Agnoli, R Tumino, C Sacerdote, A Mattiello, R Vermeulen, AK Heath, S Christakoudi, KK Tsilidis, RC Travis, MJ Gunter, HC Keun |
Gynecologic Oncology | 2021 |
|
Obesity-Related Changes in Human Plasma Lipidome Determined by the Lipidyzer Platform
P Pikó, L Pál, S Szűcs, Z Kósa, J Sándor, R Ádány |
Biomolecules | 2021 |
|
Revealing the Hypoglycemic Effects and Mechanism of GABA-Rich Germinated Adzuki Beans on T2DM Mice by Untargeted Serum Metabolomics
X Jiang, Q Xu, A Zhang, Y Liu, Z Li, H Tang, D Cao, D Zhang |
Frontiers in Nutrition | 2021 |
|
Pathways to Severe COVID‐19 for People with Obesity
O\u2019Rourke RW, Lumeng CN |
Obesity (Silver Spring, Md.) | 2021 |
|
Structure–function relationships of HDL in diabetes and coronary heart disease
Mathias Cardner, Mustafa Yalcinkaya, Sandra Goetze, Edlira Luca, Miroslav Balaz, Monika Hunjadi, Johannes J. Hartung, Andrej Shemet, Nicolle Kraenkel, Silvija Radosavljevic, Michaela Keel, Alaa Othman, Gergely Karsai, Thorsten Hornemann, Manfred Claassen, Gerhard Liebisch, Erick Carreira, Andreas Ritsch, Ulf Landmesser, Jan Kruetzfeldt, Christian Wolfrum, Bernd Wollscheid, Niko Beerenwinkel, Lucia Rohrer, Arnold von Eckardstein |
JCI Insight | 2020 |
|
Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases
S Raichur |
Frontiers in Endocrinology | 2020 |
|
Serum sphingolipids and incident diabetes in a US population with high diabetes burden: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
GC Chen, JC Chai, B Yu, GA Michelotti, ML Grove, AM Fretts, ML Daviglus, OL Garcia-Bedoya, B Thyagarajan, N Schneiderman, J Cai, RC Kaplan, E Boerwinkle, Q Qi |
The American journal of clinical nutrition | 2020 |
|
In Vitro Exposure of Leukocytes to HIV Preexposure Prophylaxis Decreases Mitochondrial Function and Alters Gene Expression Profiles
ER Bowman, C Cameron, B Richardson, M Kulkarni, J Gabriel, A Kettelhut, L Hornsby, JJ Kwiek, AN Turner, C Malvestutto, J Bazan, SL Koletar, S Doblecki-Lewis, MM Lederman, M Cameron, NR Klatt, JE Lake, NT Funderburg |
Antimicrobial agents and chemotherapy | 2020 |
|
Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer’s disease and vascular cognitive impairment
XY Chua, YL Chai, WS Chew, JR Chong, HL Ang, P Xiang, K Camara, AR Howell, F Torta, MR Wenk, S Hilal, N Venketasubramanian, CP Chen, DR Herr, MK Lai |
Alzheimer's research & therapy | 2020 |
|
High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: Evidence from two large population cohort studies
HB Beyene, G Olshansky, AA Smith, C Giles, K Huynh, M Cinel, NA Mellett, G Cadby, J Hung, J Hui, J Beilby, GF Watts, JS Shaw, EK Moses, DJ Magliano, PJ Meikle, JW Locasale |
PLoS Biology | 2020 |
|
Association of cardiac autonomic dysfunction with higher levels of plasma lipid metabolites in recent-onset type 2 diabetes
D Ziegler, A Strom, K Straßburger, B Knebel, GJ Bönhof, J Kotzka, J Szendroedi, M Roden |
Diabetologia | 2020 |
|
Associations among circulating sphingolipids, β-cell function, and risk of developing type 2 diabetes: A population-based cohort study in China
H Yun, L Sun, Q Wu, G Zong, Q Qi, H Li, H Zheng, R Zeng, L Liang, X Lin, B Yu |
PLoS Medicine | 2020 |
|
Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2
G Aji, Y Huang, ML Ng, W Wang, T Lan, M Li, Y Li, Q Chen, R Li, S Yan, C Tran, JG Burchfield, TA Couttas, J Chen, LH Chung, D Liu, C Wadham, PJ Hogg, X Gao, MA Vadas, JR Gamble, AS Don, P Xia, Y Qi |
Proceedings of the National Academy of Sciences | 2020 |
|
FADS3 is a Δ14Z sphingoid base desaturase that contributes to gender differences in the human plasma sphingolipidome
G Karsai, M Lone, Z Kutalik, JT Brenna, H Li, D Pan, A von Eckardstein, T Hornemann |
The Journal of biological chemistry | 2019 |
|
Machine learning of human plasma lipidomes for obesity estimation in a large population cohort
MJ Gerl, C Klose, MA Surma, C Fernandez, O Melander, S Männistö, K Borodulin, AS Havulinna, V Salomaa, E Ikonen, CV Cannistraci, K Simons, JW Locasale |
PLoS Biology | 2019 |
